Pacer Advisors’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
Pacer Advisors's CDNA Position: Q2 2026 in Review
Pacer Advisors opened a new position in CareDx (CDNA) in Q2 2026: 531 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #2294 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in CDNA as recently as Q2 2024.
Pacer Advisors first reported a position in CDNA in Q3 2018 and has held it in 7 quarters since. The position peaked at $139K in Q4 2020. 228 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Pacer Advisors held 531 shares of CareDx worth $15K as of Q2 2026.
- CareDx was a new Pacer Advisors position in Q2 2026.
- CareDx made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2294 holding.
- Pacer Advisors first reported a position in CareDx in Q3 2018 and has held it in 7 quarters since.
- Pacer Advisors's CareDx position peaked at $139K in Q4 2020.
- 228 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.